304 related articles for article (PubMed ID: 27221233)
1. Recent tissue engineering-based advances for effective rAAV-mediated gene transfer in the musculoskeletal system.
Rey-Rico A; Cucchiarini M
Bioengineered; 2016 Apr; 7(3):175-88. PubMed ID: 27221233
[TBL] [Abstract][Full Text] [Related]
2. Smart and Controllable rAAV Gene Delivery Carriers in Progenitor Cells for Human Musculoskeletal Regenerative Medicine with a Focus on the Articular Cartilage.
Rey-Rico A; Cucchiarini M
Curr Gene Ther; 2017; 17(2):127-138. PubMed ID: 28494738
[TBL] [Abstract][Full Text] [Related]
3. Controlled release strategies for rAAV-mediated gene delivery.
Rey-Rico A; Cucchiarini M
Acta Biomater; 2016 Jan; 29():1-10. PubMed ID: 26472612
[TBL] [Abstract][Full Text] [Related]
4. PEO-PPO-PEO micelles as effective rAAV-mediated gene delivery systems to target human mesenchymal stem cells without altering their differentiation potency.
Rey-Rico A; Venkatesan JK; Frisch J; Rial-Hermida I; Schmitt G; Concheiro A; Madry H; Alvarez-Lorenzo C; Cucchiarini M
Acta Biomater; 2015 Nov; 27():42-52. PubMed ID: 26320543
[TBL] [Abstract][Full Text] [Related]
5. New cell engineering approaches for cartilage regenerative medicine.
Cucchiarini M
Biomed Mater Eng; 2017; 28(s1):S201-S207. PubMed ID: 28372296
[TBL] [Abstract][Full Text] [Related]
6. Effective genetic modification and differentiation of hMSCs upon controlled release of rAAV vectors using alginate/poloxamer composite systems.
Díaz-Rodríguez P; Rey-Rico A; Madry H; Landin M; Cucchiarini M
Int J Pharm; 2015 Dec; 496(2):614-26. PubMed ID: 26556623
[TBL] [Abstract][Full Text] [Related]
7. rAAV-mediated overexpression of TGF-β via vector delivery in polymeric micelles stimulates the biological and reparative activities of human articular chondrocytes in vitro and in a human osteochondral defect model.
Rey-Rico A; Venkatesan JK; Schmitt G; Concheiro A; Madry H; Alvarez-Lorenzo C; Cucchiarini M
Int J Nanomedicine; 2017; 12():6985-6996. PubMed ID: 29033566
[TBL] [Abstract][Full Text] [Related]
8. Recombinant adeno-associated virus type 2-mediated gene transfer into human keratinocytes is influenced by both the ubiquitin/proteasome pathway and epidermal growth factor receptor tyrosine kinase.
Braun-Falco M; Eisenried A; Büning H; Ring J
Arch Dermatol Res; 2005 May; 296(11):528-35. PubMed ID: 15776248
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy approaches to regenerating the musculoskeletal system.
Evans CH; Huard J
Nat Rev Rheumatol; 2015 Apr; 11(4):234-42. PubMed ID: 25776949
[TBL] [Abstract][Full Text] [Related]
10. [Chemical modification of recombinant adenovirus-associated virus vectors].
Zhang D; Qiu F; Diao Y
Bing Du Xue Bao; 2013 Sep; 29(5):566-72. PubMed ID: 24386848
[TBL] [Abstract][Full Text] [Related]
11. Custom adeno-associated virus capsids: the next generation of recombinant vectors with novel tropism.
Muzyczka N; Warrington KH
Hum Gene Ther; 2005 Apr; 16(4):408-16. PubMed ID: 15871672
[TBL] [Abstract][Full Text] [Related]
12. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.
Hirsch ML; Wolf SJ; Samulski RJ
Methods Mol Biol; 2016; 1382():21-39. PubMed ID: 26611576
[TBL] [Abstract][Full Text] [Related]
13. Adeno-associated virus-mediated gene delivery.
Snyder RO
J Gene Med; 1999; 1(3):166-75. PubMed ID: 10738565
[TBL] [Abstract][Full Text] [Related]
14. Effective and durable genetic modification of human mesenchymal stem cells via controlled release of rAAV vectors from self-assembling peptide hydrogels with a maintained differentiation potency.
Rey-Rico A; Venkatesan JK; Frisch J; Schmitt G; Monge-Marcet A; Lopez-Chicon P; Mata A; Semino C; Madry H; Cucchiarini M
Acta Biomater; 2015 May; 18():118-27. PubMed ID: 25712390
[TBL] [Abstract][Full Text] [Related]
15. In utero delivery of adeno-associated viral vectors: intraperitoneal gene transfer produces long-term expression.
Lipshutz GS; Gruber CA; Cao Y ; Hardy J; Contag CH; Gaensler KM
Mol Ther; 2001 Mar; 3(3):284-92. PubMed ID: 11273769
[TBL] [Abstract][Full Text] [Related]
16. Ocular gene therapy: an evaluation of recombinant adeno-associated virus-mediated gene therapy interventions for the treatment of ocular disease.
Roy K; Stein L; Kaushal S
Hum Gene Ther; 2010 Aug; 21(8):915-27. PubMed ID: 20384478
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of TGF-β via rAAV-Mediated Gene Transfer Promotes the Healing of Human Meniscal Lesions Ex Vivo on Explanted Menisci.
Cucchiarini M; Schmidt K; Frisch J; Kohn D; Madry H
Am J Sports Med; 2015 May; 43(5):1197-205. PubMed ID: 25646364
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus and adeno-associated virus vectors.
Lai CM; Lai YK; Rakoczy PE
DNA Cell Biol; 2002 Dec; 21(12):895-913. PubMed ID: 12573049
[TBL] [Abstract][Full Text] [Related]
19. Thermosensitive Hydrogel Based on PEO-PPO-PEO Poloxamers for a Controlled In Situ Release of Recombinant Adeno-Associated Viral Vectors for Effective Gene Therapy of Cartilage Defects.
Madry H; Gao L; Rey-Rico A; Venkatesan JK; Müller-Brandt K; Cai X; Goebel L; Schmitt G; Speicher-Mentges S; Zurakowski D; Menger MD; Laschke MW; Cucchiarini M
Adv Mater; 2020 Jan; 32(2):e1906508. PubMed ID: 31763733
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy methods in bone and joint disorders. Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders, periprosthetic osteolysis and bone healing.
Ulrich-Vinther M
Acta Orthop Suppl; 2007 Apr; 78(325):1-64. PubMed ID: 17427340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]